Pulullan-based pH / redox response hydrogel PPIH preparation method and drug release method
Through the hydrogel-loaded oxidized matrine by plulandosyl pH/redox response, pH changes are used to control drug release, which solves the problem of insufficient drug release in the prior art, and achieves accurate control in different environments Sexual release, suitable for tumor treatment.
Patent Information
- Application Number
- CN202411024910.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art is difficult to effectively utilize the pH value and glutathione gradient in the tumor microenvironment to control drug release, resulting in drug release not being slow or accurate enough.
The plulandosaccharide pH/redox-reduction response hydrogel was used to control the slow release of the drug by electrostatically combining with loaded oxidized malpine by pH change, and a pH-sensitive hydrogel was formed by combining itaconic acid and crosslinking agent.
It achieves slow and controlled drug release under different pH conditions, improves the biocompatibility and release efficiency of the drug, and is suitable for tumor treatment.
Smart Images

Figure CN119019608A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of chemical drug synthesis, and in particular to a method for preparing a pullulan-based pH / redox responsive hydrogel PPIH and a drug release method. Background Art
[0002] Although the tumor microenvironment is very complex, it contains many unique physiological conditions that can be used as triggers for drug release. For example, the pH value and glutathione (GSH) gradient in the tumor change dramatically. The GSH level of tumor cells is several times that of normal cells, and its pH value is also lower than that of normal tissues. Based on these two characteristics, a pH / redox drug sustained-release carrier was designed and prepared. Pullulan is a non-ionic polysaccharide with the characteristics of neutrality, biodegradability, non-toxicity, non-immunogenicity, and non-carcinogenicity. In addition, there are a large number of hydrophilic hydroxyl functional groups in its structure, which makes it easy to chemically modify. Itaconic acid is a hydrophilic molecule with two carboxyl groups (-COOH). It is the best choice to provide pH sensitivity and increase the degree of swelling for hydrogels. Itaconic acid is an important molecule of the human endogenous immune system and has good biocompatibility. It has potential application value in the field of drug controlled release.
[0003] Oxymatrine (OMT) is a new type of anticancer drug that can not only treat cancer, but also has anti-diabetic, anti-viral, anti-inflammatory, and protective effects on the brain, liver, heart, lungs, blood vessels, gastrointestinal tract, bones, kidneys and skin. Negatively charged hydrogels can load positively charged OMT through electrostatic binding, which is affected by pH, resulting in relatively slow, pH-controlled drug release. Summary of the invention
[0004] The invention aims to prepare a hydrogel with negative charge and determine a method for controlling drug release by using oxymatrine as a carrier.
[0005] The present invention adopts the following technical scheme: a method for preparing a pullulan-based pH / redox responsive hydrogel, characterized in that a pullulan solution is added to a four-necked flask equipped with a reflux condenser, a mechanical stirrer, a thermometer and a nitrogen pipeline, and the solution is gradually heated to 70°C after nitrogen deoxygenation for 30 minutes, and then an initiator ammonium persulfate APS is slowly added, and stirring is continued for 30 minutes; after the solution is cooled to room temperature, itaconic acid IA, hydroxyethyl methacrylate HEMA and a crosslinking agent N,N'-bis(acryloyl)cystamine BAC methanol solution are added, and the mixture is continuously stirred for 10 minutes under a nitrogen atmosphere at room temperature and then transferred to a glass mold, and the final volume of the solution is adjusted to 13.5 mL with deionized water; the glass mold is sealed and placed in a water bath at 50°C, and after polymerization for 24 hours, the sample is taken out of the mold, and then immersed in deionized water for 1 week for purification to obtain a PPIH hydrogel.
[0006] Further, 200 ml of deionized water was added, and the deionized water was replaced every 12 hours to remove unreacted monomers and impurities in the hydrogel matrix.
[0007] Furthermore, oxymatrine OMT was used as a model drug to control the drug release by changing the pH value.
[0008] Compared with the prior art, the present invention has the following beneficial effects: the present invention provides a method for preparing a pullulan-based pH / redox-responsive hydrogel, wherein the negatively charged hydrogel prepared by the method can load positively charged OMT through electrostatic binding, and the electrostatic binding is affected by the pH value, thereby resulting in relatively slow drug release controlled by the pH value. BRIEF DESCRIPTION OF THE DRAWINGS
[0009] Figure 1 : Schematic diagram of PPIH hydrogel preparation;
[0010] Figure 2 FTIR patterns of Pullulan, PPIH2, and PPIH3;
[0011] Figure 3 TGA graphs of Pullulan, PIH, PPIH2, and PPIH5;
[0012] Figure 4 SEM image of the cross section of PPIH at 300 times magnification;
[0013] Figure 5 Standard curve diagram of OMT;
[0014] Figure 6 Drug loading of PPIH;
[0015] Figure 7 Drug release profile of OMT / PPIH at pH = 1.5;
[0016] Figure 8 Drug release profiles of PPIH2 at different pH values;
[0017] Fig. 9 OMT / PPIH drug release model fitting curve;
[0018] in: Fig. 9 (a)—Zero order model; (b)—First order model; (c)—Higuchi model; (d)—Korsmeyer-Peppas model. DETAILED DESCRIPTION
[0019] Embodiment 1:
[0020] like Figure 1 As shown, a certain amount of pullulan solution was added to a four-necked flask equipped with a reflux condenser, a mechanical stirrer, a thermometer and a nitrogen pipeline. After nitrogen deoxygenation for 30 minutes, the solution was gradually heated to 70°C, and then an appropriate amount of initiator ammonium persulfate (APS) was slowly added and stirred for 30 minutes. After the solution was cooled to room temperature, itaconic acid (IA), hydroxyethyl methacrylate (HEMA) and crosslinker N,N'-bis(acryloyl)cystamine (BAC) methanol solution were added, and the mixture was continuously stirred for 10 minutes under nitrogen atmosphere at room temperature and transferred to a round glass mold, and the final volume of the solution was adjusted to 13.5mL with deionized water. The glass mold was sealed and placed in a water bath at 50°C. After polymerization for 24 hours, the sample was removed from the mold and then immersed in 200mL deionized water for 1 week for purification. During this period, the deionized water was replaced every 12 hours to remove unreacted monomers and impurities in the hydrogel matrix. The raw material composition of the hydrogel is shown in Table 1.
[0021] Table 1 Composition of raw materials used to prepare hydrogel
[0022]
[0023] Infrared spectrum analysis of PPIH
[0024] Using the KBr tableting method, Pullulan, PPIH2, and PPIH3 were mixed and ground with dried KBr at a mass ratio of about 1:100. After the samples were mixed evenly, they were pressed into tablets. The samples were measured at 4000-500 cm using a VERTEX80 / 70v infrared spectrometer. -1 The absorption spectra of Pullulan, PPIH2 and PPIH3 were characterized by infrared spectroscopy. The results are as follows Figure 2 shown.
[0025] In the infrared spectrum of Pullulan, at 3322 cm -1 A broad band observed at 1004 cm-1 can be attributed to OH stretching vibration. -1 The peak at 3000 and 3400 cm-1 is the characteristic stretching of the C-OH bond in the pyranose ring. The peaks at 3000 and 3400 cm-1 are due to the OH stretching vibration of IA and HEMA and the NH stretching vibration of BAC. -1 Overlap was observed between 1708cm -1 The strong peaks near the carbonyl groups of HEMA and IA are 1069 cm-1, which is generated by COC stretching. -1 The peaks at 1446 and 1390 cm -1 The band at 1257 cm -1 The peaks near 1158 cm -1 The observed bands overlap with the bands of CN stretching vibration of BAC. The infrared spectra of PPIH2 and PPIH3 are basically consistent. It should be noted that in the spectra of PPIH2 and PPIH3, Pullulan has a peak at 1004 cm -1 The characteristic absorption band of PIH was significantly weakened. These results indicate that PIH chains were grafted onto the main chain of Pullulan.
[0026] Thermogravimetric analysis of PPIH
[0027] A STA449F3 thermogravimetric analyzer was used with a temperature range of 25°C to 600°C, a heating rate of 10°C / min, and a nitrogen flow rate of 50 mL min -1 The weight of each substance of Pullulan, PIH, PPIH2 and PPIH5 was measured. The mass change of PPIH was detected by thermogravimetric analyzer. The results are shown in Figure 3 .
[0028] The TGA results of Pullulan, PIH, PPIH2 and PPIH5 are as follows Figure 3As shown. For Pullulan, a two-stage decomposition was observed in the temperature range of 250-350℃ and 350-600℃, with weight losses of 65.6% and 75.9%, respectively, which was attributed to the thermal cleavage of the glucoside unit and the cleavage of the carbon-oxygen bond. The thermogravimetric graph of PPIH2 showed three different stages. The first was before about 148℃, which was due to the weight loss caused by the volatilization of water. The second decomposition stage was at 166℃~360℃, with a weight loss of 29.1%. The third weight loss occurred at 360~600℃, when the sample lost 93.7% of its weight. The results of the second and third stages are due to a series of complex chemical changes in the process, including the elimination of water molecules from two adjacent carboxyl groups, dehydration of glucose rings, cleavage of COC bonds in the Pululan chain, depolymerization and release of short chain fragments composed of IA and HEMA, splitting of the branched and side chain groups of the graft copolymer, and decomposition of the hydrogel network into small molecules. PPIH5 exhibits similar thermal behavior to PPIH2, however the onset temperature of the second phase of PPIH5 is slightly higher than that of PPIH2, indicating that PPIH5 has a higher thermal stability because the presence of more BACs in PPIH5 increases the cross-linking density of the network, which in turn enhances the thermal stability of PPIH.
[0029] SEM analysis of PPIH
[0030] The freeze-dried sliced hydrogel was fixed on the base, and after gold spraying, the morphology of the PPIH samples was observed using a S4800 field emission scanning electron microscope. The morphology of PPIH1-5 was analyzed using a scanning electron microscope. The results are as follows Figure 4 shown. Figure 4 The SEM image of the cross section of PPIH was magnified 300 times. The hydrogel has a porous internal structure and interconnected pores, and the pore size varies with the content of Pullulan and BAC. The pore sizes of PPIH1-3 are about 14.0μm, 22.5μm, and 37.2μm, respectively, and the pore sizes of PPIH4 and PPIH5 are about 61.6μm and 17.1μm, respectively. The pore size of the hydrogel increases with the increase of Pullulan content. With the increase of the content of the crosslinker BAC, the pore size gradually decreases. These results are mainly related to the swelling property of the hydrogel. With the increase of the Pululan content, the water absorption of the hydrogel increases, and more water is stored in the network. During the freeze-drying process, it leads to larger ice crystal aggregates, which eventually manifest as larger pore sizes. On the contrary, when the BAC content increases, the cross-linking density increases, resulting in a decrease in water content and a slightly smaller pore size after freeze-drying.
[0031] The product was analyzed by FTIR, TGA and SEM, proving that the support material was successfully prepared.
[0032] Drug loading performance test of PPIH
[0033] 1) Establishment of OMT standard curve
[0034] Weigh 50 mg of OMT, dissolve it in a 100 mL volumetric flask with PBS buffer as solvent, and take 2, 4, 6, 8, and 10 mL of the solution from the latter and place them in a 250 mL volumetric flask to make up the volume, respectively, to obtain concentrations of 4, 8, 12, 16, and 20 μg mL -1 A series of standard solutions. The maximum absorbance of OMT was determined by ultraviolet spectrophotometry to be 210 nm. The absorbance was measured at 210 nm as the detection wavelength, and a standard curve of absorbance (Y) and concentration (x) was drawn based on the measured data (see Figure 5 ), the regression equation is Y = 0.03447x + 0.0257 (R 2 =0.9997).
[0035] 2) PPIH drug loading determination
[0036] Oxymatrine (OMT) was used as a model drug to investigate the drug loading performance of different samples. A 2 mg / mL OMT solution with pH = 7.4 was prepared, a certain amount of dry gel was weighed and placed in 10 mL of the drug solution, and a constant temperature water bath oscillator was used to oscillate at 25 ° C for 48 h, the supernatant was taken, the hydrogel was rinsed with PBS solution, and freeze-dried to obtain the drug-loaded hydrogel. The drug loading (DL) of the hydrogel (OMT / PPIH) was calculated according to Formula 1:
[0037]
[0038] Where:
[0039] m1—mass of OMT embedded in the hydrogel, mg;
[0040] m2—total mass of drug-loaded hydrogel, mg;
[0041] Taking oxymatrine (OMT) as a model drug and drug loading as a standard, the drug loading performance of different samples was investigated. The drug loading rates of PPIH1-5 were 52.70%, 63.9%, 69.2%, 73.8% and 56.7%, respectively. It was found that the drug loading of the carrier increased with the increase of swelling rate.
[0042] In vitro release study of OMT / PPIH
[0043] 1) In vitro drug release curve
[0044] 1.5mL PBS was added to a dialysis bag containing drug-loaded hydrogel (molecular weight cutoff 8000-14000Da), and the two ends were tied with cotton thread, and then immersed in 33.5mL PBS buffer solution of different pH values, and oscillated at a constant temperature and speed for 32h at 37°C. 3mL of samples were taken at a fixed time point, and 3mL of fresh PBS buffer with the same pH value was added at the same time. The absorbance of the sample was measured using an ultraviolet spectrophotometer, and the cumulative release rate (CRP) was calculated. Three parallel experiments were performed under each release condition.
[0045] The cumulative drug release rate formula 2:
[0046]
[0047] Where:
[0048] V e —Release medium replacement volume, mL;
[0049] V0—total volume of release medium, mL;
[0050] C i —OMT concentration of the solution taken out for the i-th time, mg·mL -1 ;
[0051] m OMT —The mass of OMT in OMT / PPIH, mg;
[0052] n—Number of times the release medium is removed.
[0053] 2) Study on the drug release mechanism of OMT / PPIH
[0054] In order to further explore the in vitro release process of OMT / PPIH, the following four drug models were used to fit the drug release data and investigate the release characteristics of the drug in the carrier. The drug release kinetic equation is as follows:
[0055] Zero-order kinetic model:
[0056]
[0057] First-order kinetic model:
[0058]
[0059] Higuchi Model:
[0060]
[0061] Korsmeyer-Peppas Model:
[0062]
[0063] Where:
[0064] M t / M ∞ —Cumulative release percentage of drug at time t;
[0065] K0, K1, K H , K—release rate constant of zero-order, first-order, Higuchi, and Korsmeyer-Peppas models;
[0066] n—kinetic release parameter of the drug.
[0067] The in vitro release study of OMT / PPIH showed that the drug release behavior of the hydrogel was affected by the content of Pullulan and BAC. PPIH3 and PPIH1 released about 65.9% and 54.2% of OMT, respectively, within 32 hours. PPIH5 and PPIH4 released about 58.3% and 70.2% of OMT within 32 hours. The hydrogel also showed obvious pH-dependent drug release behavior. The release rate of OMT was significantly accelerated by reducing the pH from 7.4 to 1.5. At pH = 7.4 and 6.8, PPIH2 only released 23.4% and 31.4% of OMT, while at pH = 1.5, 62.5% of OMT was released. The experimental data were fitted with the Zero order, First order, Korsmeyer-Peppas and Higuchi models, and it was found that the in vitro drug release law was more consistent with the First order model.
[0068] Determination of drug loading in PPIH
[0069] In order to explore the effects of Pullulan and BAC on the drug loading of PPIH, the drug loading of PPIH1-5 was measured and analyzed. The results are shown in Figure 6 .
[0070] from Figure 6 It can be seen that the drug loading rates of PPIH1, PPIH2, and PPIH3 are 52.70%, 63.91%, and 69.15%, respectively; and the drug loading rates of PPIH4 and PPIH5 are 73.80% and 56.68%, respectively. As the Pullulan content increases or the BAC content decreases, the drug loading capacity of the hydrogel gradually increases. This may be because the swelling-diffusion method was used in the experiment to load the drug into the gel, and the pore size and swelling ability of the gel affect its drug loading capacity. The swelling rate and pore size of PPIH increase with the increase of Pullulan content or the decrease of BAC content. In summary, the loading capacity of PPIH hydrogel for OMT mainly depends on the synthesis conditions and structure of the gel itself. In vitro drug release study of OMT / PPIH
[0071] 1) Drug release properties of OMT / PPIH
[0072] In order to explore the effect of Pullulan and BAC content on the drug release performance of OMT / PPIH, the cumulative release of OMT / PPIH was investigated under pH = 1.5. The results are shown in Figure 7 .
[0073] from Figure 7 It can be seen that the drug release curve at pH = 1.5 can be divided into two stages: (I) rapid release stage (first 6 hours), in which the release of OMT by PPIH2 can reach 54.7%; (II) slow release stage (6 to 32 hours), in which PPIH2 only releases 7.8% of OMT within 26 hours. OMT carries a positive charge and can form electrostatic interactions with the negatively charged carboxyl groups on PPIH. In stage (I), the accelerated release of loaded OMT from the carrier depends on pH. The carboxyl groups remain protonated at pH = 1.5, and the electrostatic interaction between OMT molecules and the carrier becomes weaker, thereby accelerating drug release. In stage (II), the release of OMT from the carrier is controlled by the swelling-shrinking mechanism. The carboxyl groups remain protonated under acidic conditions, resulting in the formation of hydrogen bonds and exerting electrostatic repulsion, causing the hydrogel network to shrink and slow down the release rate.
[0074] The OMT / PPIH drug release behavior was also affected by the Pullulan and BAC contents. PPIH3 and PPIH1 released approximately 65.9% and 54.2% of OMT, respectively, within 32 h. The increase in Pullulan content helped the hydrogel form a looser network, through which the drug molecules could diffuse, leading to rapid release. As the BAC content decreased from PPIH5 to PPIH4, the release rate increased accordingly. PPIH5 and PPIH4 released approximately 58.3% and 70.2% of OMT within 32 h. This suggests that a relatively loose network structure can promote OMT release.
[0075] 2) Effect of pH value on drug release performance of OMT / PPIH
[0076] Taking pH as a variable, the effect of pH (1.5, 5.5, 6.8, 7.4) on the drug release performance of OMT / PPIH was investigated. The results are as follows Figure 8 shown.
[0077] like Figure 8As shown in the figure, the drug release rate of the samples is obviously dependent on pH. PPIH2 shows faster OMT release at pH = 1.5 (simulating gastric acid environment) than at pH = 5.5 (simulating the intracellular environment of diseased cells), 6.8 (simulating tumor tissue fluid) and 7.4 (simulating intestinal environment). At pH = 1.5, 5.5, 6.8, and 7.4, PPIH2 released 62.5%, 37.6%, 31.4%, and 23.4% of OMT within 32 hours, respectively. OMT carries a positive charge and can form electrostatic interactions with the negatively charged carboxyl groups on the hydrogel polymer chain, which makes it difficult for OMT to be released from the hydrogel. In the acidic environment of pH = 1.5, most of the carboxyl groups are protonated, and the reduction of electrostatic interactions will trigger the promoted release of OMT.
[0078] Study on the in vitro drug release mechanism of OMT / PPIH
[0079] In order to analyze the in vitro drug release mechanism of OMT / PPIH, four drug release models, namely Zero order, First order, Higuchi and Korsmeyer–Peppas, were used to fit the drug release data at pH = 1.5. The results are shown in Fig. 9 and Table 2.
[0080] Fig. 9 Table 2 shows that the “R 2 ” value is higher than other kinetic models, so the release curve of PPIH hydrogel is more consistent with the First Order model. 2 "The value is greater than 0.5, which indicates that the drug release is based on diffusion. The "n" value in the Korsmeyer–Peppas model determines the type of diffusion. The diffusion index "n" of the carrier in the experiment is less than 0.45, which is consistent with Fick's diffusion.
[0081] Table 2 Parameters related to drug release kinetics
[0082]
Claims
1. A method for preparing a pullulan-based pH / redox-responsive hydrogel PPIH, characterized in that: The pullulan solution was added to a four-necked flask equipped with a reflux condenser, a mechanical stirrer, a thermometer and a nitrogen pipeline. After nitrogen was passed through for 30 minutes to deoxygenate, the solution was gradually heated to 70 °C, and then the initiator ammonium persulfate APS was slowly added and stirred for 30 minutes. After the solution was cooled to room temperature, itaconic acid IA, hydroxyethyl methacrylate HEMA and crosslinker N, N'-bis(acryloyl)cystamine BAC methanol solution were added. The mixture was continuously stirred for 10 minutes under nitrogen atmosphere at room temperature and then transferred to a glass mold. The final volume of the solution was adjusted to 13.5 mL with deionized water. The glass mold was sealed and placed in a water bath at 50 °C. After 24 hours of polymerization, the sample was taken out of the mold and then immersed in deionized water for 1 week for purification to obtain PPIH hydrogel.
2. The method for preparing a pullulan-based pH / redox-responsive hydrogel PPIH according to claim 1, characterized in that: The deionized water was 200 ml, and the deionized water was replaced every 12 hours to remove unreacted monomers and impurities in the hydrogel matrix.
3. The drug release method of the PPIH hydrogel prepared by the preparation method according to claim 1, characterized in that: Oxymatrine (OMT) was used as a model drug to control drug release by changing pH.
